Manulife (Manufacturers Life Insurance)’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $305K | Sell |
|
|||||
|
2024
Q1 | $1.36M | Sell |
|
|||||
|
2023
Q4 | $1.56M | Sell |
|
|||||
|
2023
Q3 | $3.47M | Buy |
|
|||||
|
2023
Q2 | $4.64M | Buy |
|
|||||
|
2023
Q1 | $3.11M | Buy |
|
|||||
|
2022
Q4 | $3.85M | Buy |
|
|||||
|
2022
Q3 | $3.3M | Buy |
|
|||||
|
2022
Q2 | $3.07M | Buy |
|
|||||
|
2022
Q1 | $3.7M | Buy |
|
|||||
|
2021
Q4 | $650 | Sell |
|
|||||
|
2021
Q3 | $592K | Sell |
|
|||||
|
2021
Q2 | $517K | Buy |
|